Hanbio’s Human Mammary Papilla Cell Culture Fluid Listed in International Cosmetic Ingredient Dictionary

Hanbio, a cell therapy specialist, has announced that its human papilla cell culture medium (DCM) has been listed ​in the International⁤ Collection of Cosmetic Ingredients (ICID) for ‍the first time in the world.

Hanbio’s ⁤human mammary papilla cell culture fluid has been listed in the International​ Cosmetic Ingredient Dictionary (ICID) for the first time in the​ world.

This decision was made after deliberation⁤ by the Cosmetic Products Council of America (PCPC), and it⁣ is an opportunity for human mammary papilla cell culture fluid to be recognized as a ⁣global cosmetic raw material.

The human papilla cell culture fluid is a component obtained by culturing human papilla cells, and is useful for promoting scalp and hair health. Following its listing in the International Cosmetic Raw​ Material Collection, all safety tests except for the human patch test have already been completed in Korea,​ and it is ⁣currently in the process of registering as an official⁢ raw material with the Korea Cosmetic Association.

In addition, ‌the culture solution is going through the process of receiving certification from the Korea Food and Drug Safety Agency as a functional⁣ raw material⁣ for improving hair loss, suggesting the possibility⁣ of developing ⁢a functional product for preventing and treating hair loss in ‌the future.

A Hanbio official said, “This ICID listing ‌means that our research and development utilizing‍ our breast papilla cells has been ⁤recognized worldwide,” and added, “We expect to expand into various fields such as not only⁤ cosmetics ⁤but also hair loss treatments and hair ‍care products.”

Hanbio’s 3D ‌Printing Technology for Organ Manufacturing

In addition,​ Hanbio⁢ obtained a U.S. patent⁣ in December of last year for its technology⁣ to manufacture human organs⁤ and ⁣analogues based on biodegradable materials using 3D printing technology. The ​patent name is‌ ‘Method ⁢for manufacturing a plate ‌for stem cell culture that can be used for tissue engineering using 3D printing‌ for manufacturing human organ analogues.’

This technology⁣ utilizes the multipotentiality of stem cells to implement the complex organ structure of the human body in three‌ dimensions. Existing‌ organoid research ⁢had limitations in reproducing the microstructure of human ⁢organs,​ but the technology developed by ‍Hanbio has⁢ overcome these problems ⁤and implemented a ‌three-dimensional form⁤ similar to actual organs.

A HanBio official said, “This patent⁤ is a groundbreaking technology that suggests the possibility of patient-tailored organ transplantation, and is ⁣expected to open a new horizon ​for future biomedical technology.”